New World Laboratories Inc.

Presenter: Jan-Eric Ahlfors, CEO/CSO

Company Profile

New World Laboratories Inc. is a unique Canadian Biotech corporation that develops innovative breakthrough and platform technologies and therapeutics for the up & coming Regenerative Medicine industry. These technologies include: i) Cell Reprogramming technologies, ii) 3D Tissues, iii) Cell Survival Molecules, and iv) Regeneration Matrix (RMx). New World Laboratories has an innovative R&D team, an experienced management team, and a promising IP portfolio.

Company Strategy

To develop a strong IP position in the Regenerative Medicine sector by focusing on developing products for which there is a high demand, realistic FDA hurdles, and a simplified production process. The company's Cell Survival Molecules platform is planned to be licensed to a Big Pharma company in 2011, while the Cell Reprogramming and 3D Tissue platforms will be either licensed or taken into the clinic. The preclinical testing for the company's Regeneration Matrix (a device) product has been completed and could be soon taken into the clinic. The company will also continue developing new technologies and strengthen its IP position.

Intellectual Property

i) Cell Reprogramming technologies
ii) 3D Tissues (made in vitro)
iii) Cell Survival Molecules
iv) Regeneration Matrix (RMx)

Presenter Bio

Jan-Eric Ahlfors has served as the CEO of Biotech companies in the U.S., Europe, and Canada. He has pioneered a novel approach to Regenerative Medicine and his view is that the best methods of regeneration are those that mimic regenerative processes observed in nature. At age 25, while finishing his Ph.D., he founded his first Biotech company which quickly grew to become the posterchild of the regenerative medicine industry in New England. He has appeared in numerous newspaper and magazine articles both nationally and internationally, has served as a leading spokesperson for stem cells and regenerative medicine in Massachusetts and elsewhere, wrote an original version of the Massachusetts stem cell bill that came into law, is one of the youngest individuals ever to receive an O-1 ("Extraordinary Ability") status from the U.S. government, and was awarded the State of Massachusetts 2004 "Businessman of the Year" title award from the National Republican Congressional Committee. He has degrees in biotechnology, physics, biomedical engineering, and an MBA in the Management of Technology from the Worcester Polytechnic Institute, and holds a record on the greatest number of classes ever taken in the University's 145-year history. He received his laboratory research training at the University of Massachusetts Medical School and Harvard consortium under Drs. Vacanti.

Contact

New World Laboratories Inc.
500 Cartier Boulevard West
Laval
Quebec, Canada
H7V 5B7

ph: (450) 781-2155 x2100
fx: (450) 781-2199

www.nwl.net
j.ahlfors@nwl.net